Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (Q33751186)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma |
scientific article |
Statements
1 reference
Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (English)
1 reference
C H Chung
1 reference
J Aulino
1 reference
N J Muldowney
1 reference
H Hatakeyama
1 reference
J Baumann
1 reference
B Burkey
1 reference
J Netterville
1 reference
R Sinard
1 reference
W G Yarbrough
1 reference
A J Cmelak
1 reference
R J Slebos
1 reference
Y Shyr
1 reference
J Parker
1 reference
J Gilbert
1 reference
B A Murphy
1 reference
22 October 2009
1 reference
1 reference
21
1 reference
864-870
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference